Two Sigma Advisers’s St Jude Medical STJ Stock Holding History

Two Sigma Advisers’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,000	Closed	-$346K	–	2868
2014 Q2	$346K	Buy	5,000 +1,000	+25%	+$64.8K	﹤0.01%	1921
2014 Q1	$262K	Sell	4,000 -2,000	-33%	-$130K	﹤0.01%	1954
2013 Q4	$372K	Buy	6,000 +1,000	+20%	+$57.9K	﹤0.01%	1780
2013 Q3	$268K	Sell	5,000 -9,300	-65%	-$479K	﹤0.01%	1754
2013 Q2	$653K	Buy	+14,300	New	+$620K	0.01%	1145

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Two Sigma Advisers's STJ Position: Q1 2017 in Review

Two Sigma Advisers sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 475,470 shares — an estimated $38.1M sold.

Two Sigma Advisers first reported a position in STJ in Q1 2014 and held it in 12 quarters. The position peaked at $83.1M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Two Sigma Advisers reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Two Sigma Advisers sold 475,470 St Jude Medical shares in Q1 2017, an estimated $38.1M.
Two Sigma Advisers first reported a position in St Jude Medical in Q1 2014 and held it in 12 quarters.
Two Sigma Advisers's St Jude Medical position peaked at $83.1M in Q2 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Two Sigma Advisers's 13F filing for Q1 2017, filed 15 May 2017.